Status:

COMPLETED

Non-concealed Placebo Treatment for Menopausal Hot Flushes

Lead Sponsor:

Universitätsklinikum Hamburg-Eppendorf

Conditions:

Hot Flashes

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

It has been long viewed that placebos cannot be administered in accordance with ethical values because deception is instrumental to the placebo effect. This notion has been shaken up by studies on ope...

Detailed Description

Beneficial effects of double-blind placebos were found to be high in hot flush trials. Recent studies demonstrating the efficacy of placebos without concealment provide a possible way to administer pl...

Eligibility Criteria

Inclusion

  • at least 5 moderate or severe hot flushes per day, including night time
  • all hot flushes have at least moderate ratings of bother (sum score ≥ 16 on the bother subscale of the Hot Flush Rating Scale (HFRS) \[41\]
  • fluency in German language
  • participants are in menopausal transition (irregularities ≥ 60 days in the past year), or postmenopausal (cessation of menstruation ≥ 1 year) \[42\].

Exclusion

  • use of hormonal therapy to treat hot flushes within the last 6 weeks before enrolment
  • use of herbal remedies to treat hot flushes within the last 6 weeks before enrolment
  • intake of selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRI) within the last 6 weeks before enrolment
  • previous oophorectomy
  • severe physical or cognitive impairments which would constitute a barrier to give informed consent
  • severe depression and anxiety (≥ 9 sum score or ≥ 5 depression or anxiety subscore on the Patient Health Questionnaire-4)
  • medical conditions which might interact with menopausal hot flushes such as untreated hyperthyroidism, alcohol abuse (excluded when ≥4 on AUDIT-C) and cancer

Key Trial Info

Start Date :

February 12 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 5 2020

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03838523

Start Date

February 12 2019

End Date

March 5 2020

Last Update

February 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center Hamburg-Eppendorf

Hamburg, Germany, 20251

Non-concealed Placebo Treatment for Menopausal Hot Flushes | DecenTrialz